指南与共识乳腺US

乳腺超声上簇状微囊肿:何种管理建议是合适的?

Clustered Microcysts on Breast Ultrasound: What Is an Appropriate Management Recommendation?
指南 / 共识 · AJR Am J Roentgenol · 2017-09-20

该回顾性研究纳入2003年1月至2013年12月本机构乳腺超声分类为簇状微囊肿且有充分随访的95个病灶(93例患者),其中16个病灶经皮穿刺取样均无恶性(0%,95%CI 0-21%),全部95个病灶在取样或影像随访中均无恶性(0%,95%CI 0-3.8%),结论支持此类病灶恶性风险极低,应避免活检。

要点

  • 乳腺超声表现为簇状微囊肿的病灶恶性风险极低,95个病灶中0个恶性(0%,95%CI 0-3.8%)。
  • 16个经皮穿刺取样的病灶均未发现恶性(0%,95%CI 0-21%),其中2个穿刺示非典型导管增生但手术切除无升级。
  • 作者结论支持对超声表现为簇状微囊肿的病灶避免活检。

核心结论

  • 超声表现为簇状微囊肿的病灶恶性风险极低,作者结论支持应避免活检。

研究设计与样本

  • 回顾性研究,2003年1月至2013年12月本机构病例,最终纳入93例患者共95个超声分类为簇状微囊肿且有充分随访的病灶;超声检查由阅片医师完成,取样结果取自病理或细胞学报告,未取样者仅纳入至少24个月影像随访或任何影像随访期间病灶消退或缩小的病例。

关键影像表现/征象

  • 乳腺超声上病灶被分类为簇状微囊肿。
  • 16个病灶接受经皮取样,其中14个(88%)为良性,2个(12%)穿刺示非典型导管增生但后续手术切除无异常增生或升级。
  • 全部95个病灶在取样或影像随访中均无恶性(0%,95%CI 0-3.8%)。

诊断标准与关键数值

  • 以穿刺取样病理/细胞学或影像随访为参考,簇状微囊肿病灶恶性率为0%(0/95,95%CI 0-3.8%)。
  • 经皮取样病灶中恶性率为0%(0/16,95%CI 0-21%)。

临床应用与阅片要点

  • 作者结论支持超声表现为簇状微囊肿的病灶应避免活检。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The objective of our study was to determine outcomes of lesions identified as clustered microcysts on breast ultrasound to augment the existing literature and help guide appropriate management recommendations.

MATERIALS AND METHODS: We retrospectively identified cases at our institution, from January 2003 through December 2013, of all lesions classified as clustered microcysts at breast ultrasound. Breast ultrasound examinations were performed by the interpreting physician. If ultrasound-guided sampling was performed, results were obtained from the pathology or cytology reports. If sampling was not performed, only lesions with at least 24 months of imaging follow-up or any imaging follow-up with interval resolution or decrease in size were included in the study. Outcomes and frequency of malignancy were determined by reviewing the electronic medical records and our PACS.

RESULTS: Of 144 patients with 148 lesions classified as clustered microcysts on ultrasound, 93 patients with 95 lesions had adequate follow-up and were included in our study population. The mean patient age was 50 years (range, 32-72 years). Of the 16 lesions that underwent percutaneous sampling, none (0% [95% CI, 0-21%]) yielded malignancy. Fourteen (88%) sampled lesions were benign, and two (12%) of the sampled lesions revealed atypical ductal hyperplasia at percutaneous sampling but no atypia or upgrade at subsequent surgical excision. In total, 0 of 95 lesions (0% [95% CI, 0-3.8%]) showed malignancy at sampling or imaging follow-up.

CONCLUSION: Our results support that lesions sonographically characterized as clustered microcysts carry an extremely low risk of malignancy, and biopsy should be avoided.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Greenwood HI, Lee AY, Lobach IV, et al. Clustered Microcysts on Breast Ultrasound: What Is an Appropriate Management Recommendation? AJR Am J Roentgenol. 2017. PMID: 28929806. doi:10.2214/AJR.17.17813

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。